Lappaconitine Hydrobromide Tablets
Function and Efficacy
Pharmacology: This product is a non-addictive analgesic with strong analgesic effect. This product also has local anesthetic, cooling, antipyretic and anti-inflammatory effects. Compared with pethidine, this product has equivalent analgesic effect, with a slightly slower onset time and a longer duration of maintenance; the analgesic effect is 7 times that of the antipyretic analgesic aminopyrine. Toxicology: This product has no teratogenic effect in animal experiments. Acute toxicity test results: oral LD50 for rats is 20 mg/Kg; intraperitoneal injection LD50 for mice is 9.1 mg/Kg, and intravenous injection LD50 is 6.9 mg/Kg.
Ingredients
The main ingredients of this product are: Laconutin hydrobromide
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LAPPACONITINE HYDROBROMIDEIngredients |
A non-addictive analgesic with strong analgesic, local anesthetic, cooling, antipyretic and anti-inflammatory effects. Compared with pethidine, it has comparable analgesic effects, but takes a little longer to take effect, while lasting longer. Its analgesic effect is 7 times that of the antipyretic analgesic aminopyrine. More |
97792-45-5 | 3 |
Appearance
This product is a sugar-coated tablet, which appears white after removing the sugar coating.
Indication
Used for moderate to severe pain.
Usage and Dosage
Oral administration for adults: 5-10 mg at a time, 1-3 times a day.
Adverse Reactions
Some patients experienced urticaria, palpitations, chest tightness, dizziness, etc., which disappeared quickly after stopping the medication.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Keep away from light and sealed
Packaging Specification
5mg
Validity Period
24 months
Manufacturer
Guangxi Wuzhou Shennong Pharmaceutical Co., Ltd.
-
Founded in:
2000-03-27 -
Address:
No. 8, Dachongli, Qianjian Road, Wuzhou City, Guangxi -
Tax NO.:
9145040071512092X9 -
Registered Funds:
22.937099 yuan -
Website:
-
Email: